Moreover, the analysis of flow cytometry on tumor tissues demonstrated that the combination of Tyra and immunotherapy significantly increased the infiltration level (Figure 6C) and promoted the activation (Figure 6, D and E) of CD8+ T cells. Here, CD8A is linked to neoplasm.